Literature DB >> 20729552

ZEB1 coordinately regulates laminin-332 and {beta}4 integrin expression altering the invasive phenotype of prostate cancer cells.

Justin M Drake1, J Matthew Barnes, Joshua M Madsen, Frederick E Domann, Christopher S Stipp, Michael D Henry.   

Abstract

Metastasis involves the invasion of cancer cells across both the extracellular matrix and cellular barriers, and an evolving theme is that epithelial-to-mesenchymal transition (EMT) may mediate invasive cellular behavior. Previously, we isolated and analyzed a subpopulation of PC-3 prostate cancer cells, TEM4-18, and found that these cells both invaded an endothelial barrier more efficiently and exhibited enhanced metastatic colonization in vivo. Transendothelial migration of these cells depended on expression of ZEB1, a known regulator of EMT. Surprisingly, these cells were much less invasive than parental PC-3 cells in assays that involve matrix barriers. Here, we report that TEM4-18 cells express significantly reduced levels of two subunits of laminin-332 (β3 and γ2) and that exogenous laminin-332, or co-culture with laminin-332-expressing cells, rescues the in vitro invasion phenotype in these cells. Stable knockdown of ZEB1 in prostate cancer cells up-regulated LAMC2 and ITGB4 mRNA and protein and resulted in a concomitant increase in Transwell migration. Using chromatin immunoprecipitation (ChIP), we show that ZEB1 directly interacts with the promoters of LAMC2 and ITGB4. These results provide a novel molecular basis for reduced laminin-332 observed in clinical prostate cancer specimens and demonstrate a context-dependent role for EMT in invasive cellular behavior.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729552      PMCID: PMC2962494          DOI: 10.1074/jbc.M110.136044

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin.

Authors:  F Hlubek; A Jung; N Kotzor; T Kirchner; T Brabletz
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

2.  ZEB represses transcription through interaction with the corepressor CtBP.

Authors:  A A Postigo; D C Dean
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion.

Authors:  L M Shaw; I Rabinovitz; H H Wang; A Toker; A M Mercurio
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

4.  Downregulation of the beta4 integrin subunit in prostatic carcinoma and prostatic intraepithelial neoplasia.

Authors:  M V Allen; G J Smith; R Juliano; S J Maygarden; J L Mohler
Journal:  Hum Pathol       Date:  1998-04       Impact factor: 3.466

5.  Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5.

Authors:  G Giannelli; J Falk-Marzillier; O Schiraldi; W G Stetler-Stevenson; V Quaranta
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

6.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

7.  Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate.

Authors:  J Hao; Y Yang; K M McDaniel; B L Dalkin; A E Cress; R B Nagle
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

8.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

9.  Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia.

Authors:  I Sordat; F T Bosman; G Dorta; P Rousselle; D Aberdam; A L Blum; B Sordat
Journal:  J Pathol       Date:  1998-05       Impact factor: 7.996

Review 10.  The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression.

Authors:  A E Cress; I Rabinovitz; W Zhu; R B Nagle
Journal:  Cancer Metastasis Rev       Date:  1995-09       Impact factor: 9.264

View more
  35 in total

1.  MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Authors:  Keun Hur; Yuji Toiyama; Masanobu Takahashi; Francesc Balaguer; Takeshi Nagasaka; Junichi Koike; Hiromichi Hemmi; Minoru Koi; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2012-06-26       Impact factor: 23.059

2.  Zinc finger E-box binding homeobox-1 (Zeb1) drives anterograde lysosome trafficking and tumor cell invasion via upregulation of Na+/H+ Exchanger-1 (NHE1).

Authors:  Samantha S Dykes; ChongFeng Gao; William K Songock; Rebecca L Bigelow; George Vande Woude; Jason M Bodily; James A Cardelli
Journal:  Mol Carcinog       Date:  2016-08-22       Impact factor: 4.784

3.  Id2 complexes with the SNAG domain of Snai1 inhibiting Snai1-mediated repression of integrin β4.

Authors:  Cheng Chang; Xiaofang Yang; Bryan Pursell; Arthur M Mercurio
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

4.  Grainyhead-like 2 downstream targets act to suppress epithelial-to-mesenchymal transition during neural tube closure.

Authors:  Heather J Ray; Lee A Niswander
Journal:  Development       Date:  2016-02-22       Impact factor: 6.868

5.  DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Authors:  Jonathan F Goodwin; Vishal Kothari; Justin M Drake; Shuang Zhao; Emanuela Dylgjeri; Jeffry L Dean; Matthew J Schiewer; Christopher McNair; Jennifer K Jones; Alvaro Aytes; Michael S Magee; Adam E Snook; Ziqi Zhu; Robert B Den; Ruth C Birbe; Leonard G Gomella; Nicholas A Graham; Ajay A Vashisht; James A Wohlschlegel; Thomas G Graeber; R Jeffrey Karnes; Mandeep Takhar; Elai Davicioni; Scott A Tomlins; Cory Abate-Shen; Nima Sharifi; Owen N Witte; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

6.  Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.

Authors:  Zhaohui He; Fucai Tang; Zechao Lu; Yucong Huang; Hanqi Lei; Zhibiao Li; Guohua Zeng
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 7.  Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma.

Authors:  C S Scanlon; E A Van Tubergen; R C Inglehart; N J D'Silva
Journal:  J Dent Res       Date:  2012-11-05       Impact factor: 6.116

8.  Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.

Authors:  Brian Bierie; Sarah E Pierce; Cornelia Kroeger; Daniel G Stover; Diwakar R Pattabiraman; Prathapan Thiru; Joana Liu Donaher; Ferenc Reinhardt; Christine L Chaffer; Zuzana Keckesova; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

9.  Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization.

Authors:  Afshin Varzavand; Justin M Drake; Robert U Svensson; Mary E Herndon; Bo Zhou; Michael D Henry; Christopher S Stipp
Journal:  Clin Exp Metastasis       Date:  2012-12-06       Impact factor: 5.150

10.  Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.

Authors:  Alison K Esser; Michael R Miller; Qin Huang; Melissa M Meier; Daniel Beltran-Valero de Bernabé; Christopher S Stipp; Kevin P Campbell; Charles F Lynch; Brian J Smith; Michael B Cohen; Michael D Henry
Journal:  J Biol Chem       Date:  2012-12-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.